{"url_path":"/sec/esla/10-q/2026/item-1a","section_key":"item-1a","section_title":"Item 1A RISK FACTORS**","topic":"sec","document":{"doc_type":"10-Q","doc_date":"2026-05-18","source_url":"https://www.sec.gov/Archives/edgar/data/1844417/0001213900-26-058063-index.html","accession_number":"0001213900-26-058063","cik":"0001844417","ticker":"ESLA","issuer_name":"Estrella Immunopharma, Inc.","edgar_url":"https://www.sec.gov/Archives/edgar/data/1844417/0001213900-26-058063-index.html","primary_entity_key":"0001844417","primary_entity_name":"Estrella Immunopharma, Inc."},"word_count":123,"has_tables":true,"body_markdown":"**ITEM 1A. RISK FACTORS**\n\n \n\nFactors that could cause\nour actual results to differ materially from those included in this Quarterly Report are any of the risks described under “*Risk\nFactors*” in our Annual Report on Form 10-K filed with the SEC on March 18, 2026. Any of these factors could result in a significant\nor material adverse effect on our results of operations or financial condition. Additional risk factors not presently known to us or\nthat we currently deem immaterial may also impair our business or results of operations. As of the date of this Quarterly Report, there\nhave been no material changes to the risk factors disclosed in our Annual Report on Form 10-K filed with the SEC on March 18, 2026."}